Home » Stocks » CVET

Covetrus, Inc. (CVET)

Stock Price: $25.17 USD 0.53 (2.15%)
Updated Jul 23, 2021 4:00 PM EDT - Market closed
After-hours: $25.01 -0.16 (-0.64%) Jul 23, 4:50 PM
Market Cap 3.44B
Revenue (ttm) 4.38B
Net Income (ttm) -1,000,000
Shares Out 136.00M
EPS (ttm) -0.07
PE Ratio n/a
Forward PE 28.49
Dividend n/a
Dividend Yield n/a
Trading Day July 23
Last Price $25.17
Previous Close $24.64
Change ($) 0.53
Change (%) 2.15%
Day's Open 24.76
Day's Range 24.24 - 25.34
Day's Volume 461,405
52-Week Range 18.74 - 40.78

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

PORTLAND, Maine--(BUSINESS WIRE)---- $CVET--Covetrus Appoints New Chief Accounting Officer

3 days ago - Business Wire

PORTLAND, Maine & IRVINE, Calif.--(BUSINESS WIRE)---- $CVET--Covetrus has entered into a definitive agreement to acquire VCP, a market-leading platform in veterinary wellness plan administration.

3 weeks ago - Business Wire

Covetrus (CVET) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

3 weeks ago - Zacks Investment Research

PORTLAND, Maine--(BUSINESS WIRE)---- $CVET--Covetrus appoints Bekki Kidd and András Bolcskei to the roles of head of North America Operations and president of International, respectively.

4 weeks ago - Business Wire

PORTLAND, Maine--(BUSINESS WIRE)---- $CVET--Covetrus enhanced their leading practice management software to help veterinary clinics compete online and deliver more complete healthcare.

1 month ago - Business Wire

Covetrus (CVET) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength dow...

1 month ago - Zacks Investment Research

PORTLAND, Maine--(BUSINESS WIRE)---- $CVET--Covetrus appoints Paul Fonteyne, pharmaceutical and animal healthcare veteran, to its Board of Directors.

2 months ago - Business Wire

Covetrus (CVET) delivered earnings and revenue surprises of 22.22% and 1.84%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

PORTLAND, Maine--(BUSINESS WIRE)---- $CVET #earnings--Covetrus, Inc. (Nasdaq: CVET), announced financial results for the first quarter of 2021, which ended March 31, 2021.

2 months ago - Business Wire

PORTLAND, Maine--(BUSINESS WIRE)---- $CVET--Covetrus announced that healthcare and pharmaceutical veteran Pete Perron has joined the company as president of strategic partnerships.

2 months ago - Business Wire

PORTLAND, Maine--(BUSINESS WIRE)---- $CVET #earnings--Covetrus will release Q1 2021 results after the market closes on Thursday, May 6, 2021 and the company will hold a conference call at 4:30 PM ET.

2 months ago - Business Wire

Our furry friends have taken care of us during this terrible pandemic. Now it's time to take care of them with these pet stocks to buy.

Other stocks mentioned: CENT, CHWY, CLX, HSKA, LMND
3 months ago - InvestorPlace

PORTLAND, Maine--(BUSINESS WIRE)---- $CVET--Covetrus announced the addition of Stacey M.M. Shirra as vice president of global talent management.

4 months ago - Business Wire

Covetrus (CVET) delivered earnings and revenue surprises of 25.00% and 5.88%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

4 months ago - Zacks Investment Research

PORTLAND, Maine--(BUSINESS WIRE)---- $CVET #earnings--Covetrus reported financial results for the fourth quarter and full-year 2020, which ended December 31, 2020.

4 months ago - Business Wire

PORTLAND, Maine--(BUSINESS WIRE)---- $CVET #animalhealth--Covetrus appoints Link Welborn, DVM, DABVP as Covetrus' chief veterinary officer (CVO) in North America.

5 months ago - Business Wire

PORTLAND, Maine--(BUSINESS WIRE)---- $CVET #earnings--Covetrus will release fourth quarter and full-year 2020 results the morning of Monday, March 1, 2021.

5 months ago - Business Wire

PORTLAND, Maine--(BUSINESS WIRE)---- $CVET--Covetrus announced the appointment of its first-ever chief consumer officer.

5 months ago - Business Wire

LONDON & PORTLAND, Maine--(BUSINESS WIRE)--Covetrus received top recognition from the Learning Technologies Awards for its project with Dogs Trust, the largest dog welfare charity in the UK.

5 months ago - Business Wire

Covetrus, Inc. presents as a value proposition on a backdrop of incremental growth and successful acquisition integrations. Success in the high margin prescription management segment acts as a key growt...

6 months ago - Seeking Alpha

PORTLAND, Maine--(BUSINESS WIRE)-- #animalhealth--Animal-health technology and services company, Covetrus, to participate in the 39th Annual J.P. Morgan Healthcare Conference.

6 months ago - Business Wire

Does Covetrus (CVET) have what it takes to be a top stock pick for momentum investors? Let's find out.

6 months ago - Zacks Investment Research

Covetrus (CVET) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

7 months ago - Zacks Investment Research

Finding cheap stocks isn't just about price -- it's about finding great companies that are trading at a discout to their actual worth. The post 5 Cheap Stocks With Great-Performing Companies appeared fi...

Other stocks mentioned: AB, ATCO, CODI, GTN
7 months ago - InvestorPlace

PORTLAND, Maine--(BUSINESS WIRE)--Covetrus completes separation from former parent company ahead of schedule enabling the Company to deliver greater coordination of its businesses.

7 months ago - Business Wire

More households own pets than have children, and they'll pay to keep their furry friends happy. Here are 6 big pet stocks.

Other stocks mentioned: FDS, HSIC, MRK, NSRGY, ZTS
7 months ago - InvestorPlace

Covetrus (CVET) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

7 months ago - Zacks Investment Research

Does Covetrus (CVET) have what it takes to be a top stock pick for momentum investors? Let's find out.

8 months ago - Zacks Investment Research

Covetrus' (CVET) CEO Ben Wolin on Q3 2020 Results - Earnings Call Transcript

8 months ago - Seeking Alpha

Covetrus (CVET) delivered earnings and revenue surprises of 43.75% and 8.17%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

8 months ago - Zacks Investment Research

Shares of Covetrus (NASDAQ:CVET) were flat in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share were up 52.94% year over year to $0.26, which beat the esti...

8 months ago - Benzinga

PORTLAND, Maine, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Covetrus, Inc. (Nasdaq: CVET), a global leader in animal-health technology and services, today announced financial results for the third quarter of 202...

8 months ago - GlobeNewsWire

CVET vs. CRWD: Which Stock Is the Better Value Option?

Other stocks mentioned: CRWD
8 months ago - Zacks Investment Research

Covetrus (CVET) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

8 months ago - Zacks Investment Research

PORTLAND, Maine, Oct. 27, 2020 (GLOBE NEWSWIRE) -- Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, announced today that it will release third quarter 2020 results afte...

8 months ago - GlobeNewsWire

Covetrus (CVET) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

8 months ago - Zacks Investment Research

Does Covetrus (CVET) have what it takes to be a top stock pick for momentum investors? Let's find out.

9 months ago - Zacks Investment Research

CVET vs. CRWD: Which Stock Is the Better Value Option?

Other stocks mentioned: CRWD
9 months ago - Zacks Investment Research

Chewy, Zoetis and FreshPet are just a couple of the names on our list of pet stocks to buy. Let's look at this growing industry more closely.

Other stocks mentioned: CHWY, FRPT, IDXX, PETS, SJM, ZTS
9 months ago - InvestorPlace

PORTLAND, Maine--(BUSINESS WIRE)--Covetrus made a strategic investment in VSG, the leading provider of peer-to-peer learning experiences for veterinary practice leaders.

9 months ago - Business Wire

Covetrus, Inc. (NASDAQ : CVET; $22.98; Market Capitalization: $2.6 billion) is on a path of fast-tracked recovery as the company has managed to successfully reboot its operations in the U. S., where COV...

9 months ago - Forbes

PORTLAND, Maine--(BUSINESS WIRE)--Covetrus announced the agenda and speaker lineup for its annual VetSummit conference that is to take place October 16-18.

9 months ago - Business Wire

Despite the economic challenges of the pandemic, Americans are spoiling their pets. Profit from that hot market with these top growth stocks.

Other stocks mentioned: AMZN, MRK, NSRGY, ZTS
10 months ago - InvestorPlace

PORTLAND, Maine--(BUSINESS WIRE)--Covetrus, a global leader in animal-health technology & services, announces appointment of Jamey Seely as general counsel effective Sept. 1, 2020.

10 months ago - Business Wire

PHOENIX--(BUSINESS WIRE)--Covetrus donated 6,000 bottles of hand sanitizer to help protect Phoenix communities and Arizona medical personnel from coronavirus.

11 months ago - Business Wire

CVET vs. SOGO: Which Stock Is the Better Value Option?

Other stocks mentioned: SOGO
11 months ago - Zacks Investment Research

Does Covetrus (CVET) have what it takes to be a top stock pick for momentum investors? Let's find out.

11 months ago - Zacks Investment Research

Covetrus Inc. (CVET) CEO Ben Wolin on Q2 2020 Results - Earnings Call Transcript

11 months ago - Seeking Alpha

Shares of Covetrus (NASDAQ:CVET) were flat in after-market trading after the company reported Q2 results.

11 months ago - Benzinga

Covetrus (CVET) delivered earnings and revenue surprises of 137.50% and 13.89%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

11 months ago - Zacks Investment Research

About CVET

Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers. The company also offers value-added solutions that in... [Read more...]

Industry
Health Information Services
Stock Exchange
NASDAQ
Ticker Symbol
CVET
Full Company Profile

Financial Performance

In 2020, Covetrus's revenue was $4.34 billion, an increase of 9.13% compared to the previous year's $3.98 billion. Losses were -$19.00 million, -98.06% less than in 2019.

Financial Statements

Analyst Forecasts

According to 7 analysts, the average rating for Covetrus stock is "Buy." The 12-month stock price forecast is 33.83, which is an increase of 34.41% from the latest price.

Price Target
$33.83
(34.41% upside)
Analyst Consensus: Buy